Pembrolizumab-induced myasthenia gravis: Two patients’ experiences
Checkpoint inhibitors are increasingly used to treat patients with gynecologic malignancies and can cause rare and unusual side effects, also known as immunotoxicities, that are rarely observed in patients receiving traditional immunotherapy. If these are not identified and treated, they can cause d...
Na minha lista:
| Principais autores: | , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Elsevier
2024-08-01
|
| 叢編: | Gynecologic Oncology Reports |
| 主題: | |
| 在線閱讀: | http://www.sciencedirect.com/science/article/pii/S2352578924001322 |
| 標簽: |
沒有標簽, 成為第一個標記此記錄!
|